These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4227918)

  • 41. The effect of streptokinase on the fibrin binding site of plasmin(ogen).
    Cederholm-Williams SA
    Thromb Res; 1981 Mar; 21(6):649-54. PubMed ID: 6455776
    [No Abstract]   [Full Text] [Related]  

  • 42. Interaction of a group A Streptococcus within human plasma results in assembly of a surface plasminogen activator that contributes to occupancy of surface plasmin-binding structures.
    D'Costa SS; Boyle MD
    Microb Pathog; 1998 Jun; 24(6):341-9. PubMed ID: 9632538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasminogen activator activities of equimolar complexes of streptokinase with variant recombinant plasminogens.
    Davidson DJ; Higgins DL; Castellino FJ
    Biochemistry; 1990 Apr; 29(14):3585-90. PubMed ID: 2141279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasmin can activate plasma prorenin but is not required for the alkaline phase of acid activation.
    Sealey JE; Atlas SA; Laragh JH; Silverberg M; Kaplan AP
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():97s-99s. PubMed ID: 44236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasminogen activator inhibitor type-1 determines plasmin formation in patients with ischaemic heart disease.
    Pedersen OD; Gram J; Jespersen J
    Thromb Haemost; 1995 May; 73(5):835-40. PubMed ID: 7482412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Crystal structure of the catalytic domain of human plasmin complexed with streptokinase.
    Wang X; Lin X; Loy JA; Tang J; Zhang XC
    Science; 1998 Sep; 281(5383):1662-5. PubMed ID: 9733510
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The reliability of plasminogen estimation by activation potential. On the heterogeneity of plasminogen in human plasma.
    Wolf P
    Bibl Anat; 1973; 12():286-91. PubMed ID: 4275206
    [No Abstract]   [Full Text] [Related]  

  • 48. Pathogen activators of plasminogen.
    Verhamme IM; Panizzi PR; Bock PE
    J Thromb Haemost; 2015 Jun; 13 Suppl 1(0 1):S106-14. PubMed ID: 26149011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dysplasminogenemias.
    Robbins KC
    Prog Cardiovasc Dis; 1992; 34(4):295-308. PubMed ID: 1530828
    [No Abstract]   [Full Text] [Related]  

  • 50. Methods for studying fibrinolytic pathway components in human plasma.
    Wohl RC; Sinio L; Robbins KC
    Thromb Res; 1982 Sep; 27(5):523-35. PubMed ID: 6217585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Staphylokinase--a specific plasminogen activator].
    Rozpończyk E; Szemraj J; Malinowski M; Rozpończyk J
    Postepy Biochem; 2006; 52(1):80-6. PubMed ID: 16869305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of plasmin(ogen) acquisition by clinical isolates of group A streptococci incubated in human plasma.
    Wang H; Lottenberg R; Boyle MD
    J Infect Dis; 1994 Jan; 169(1):143-9. PubMed ID: 8277175
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FIBRINOLYSIS AND FIBRINOLYTIC AGENTS IN CLINICAL PRACTICE. (WITH SPECIAL REFERENCE TO STREPTOKINASE).
    JAMES DC; BROWSE NL
    Br J Clin Pract; 1964 Jun; 18():343-56. PubMed ID: 14169065
    [No Abstract]   [Full Text] [Related]  

  • 54. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.
    Crabbe SJ; Grimm AM; Hopkins LE
    Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isolation of an active derivative produced from native streptokinase by dog plasmin.
    Reddy KN; Kline DL
    Thromb Res; 1976 Oct; 9(4):407-11. PubMed ID: 136060
    [No Abstract]   [Full Text] [Related]  

  • 56. The human plasma fibrinolytic system: regulation and control.
    Robbins KC
    Mol Cell Biochem; 1978 Aug; 20(3):149-57. PubMed ID: 151804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ATP-regulated activity of the plasmin-streptokinase complex: a novel mechanism involving phosphorylation of streptokinase.
    Serrano RL; Rodriguez P; Pizzo SV; Gonzalez-Gronow M
    Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):171-7. PubMed ID: 8546680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acyl-enzymes as thrombolytic agents in a rabbit model of venous thrombosis.
    Smith RA; Dupe RJ; English PD; Green J
    Thromb Haemost; 1982 Jun; 47(3):269-74. PubMed ID: 6214039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of complex formation between plasmin(ogen) and staphylokinase or streptokinase.
    Okada K; Ueshima S; Fukao H; Matsuo O
    Arch Biochem Biophys; 2001 Sep; 393(2):339-41. PubMed ID: 11556822
    [No Abstract]   [Full Text] [Related]  

  • 60. Activation of bovine plasminogen by Streptococcus uberis.
    Leigh JA
    FEMS Microbiol Lett; 1993 Nov; 114(1):67-71. PubMed ID: 8293961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.